Nanophase Reports Stronger First Quarter 2013 Financial Results

Revenue Higher Than Any Quarter of 2012


ROMEOVILLE, Ill., May 1, 2013 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB:NANX), a technology leader in nanomaterials and advanced nanoengineered products, today reported financial results for the first quarter, ended March 31, 2013.

Nanophase CEO and President Jess Jankowski commented, "We had a strong first quarter, continuing our improved results. This $3.0 million of revenue exceeded that of any quarter in 2012. Not surprisingly, this improvement shows on the bottom line." 

First Quarter 2013 Financial Highlights

  • Revenue for the quarter was $3.0 million compared to revenue of $2.4 million for the comparable 2012 quarter, a 24 percent increase. Gross margin was 30% for the first quarter 2013, vs. 23% during the first quarter 2012.
     
  • The net loss for the quarter was $0.5 million, or a loss of $0.02 per share, compared to a net loss of $0.8 million, or $0.04 per share, for the comparable 2012 quarter. 
     
  • The Company finished the quarter with approximately $3.6 million in cash and cash equivalents on the balance sheet; the company has no debt.   

"While the first quarter is typically a better quarter for Nanophase, I like where we are positioned," continued Jankowski, "we are focused on accelerating our business development, and have been not only developing new products faster, but we also expect them to have stronger value propositions going forward. While we are very pleased with our progress, we still have work to do toward achieving our goal of sustainable, profitable growth. Our next major goal is to see quarterly positive net results that extend into significant, repeatable cash flows."

First Quarter 2013 Conference Call 

The Nanophase conference call, to be hosted by Jess Jankowski, the Company's CEO and President, is scheduled for May 2, 2013, at 10:00 a.m. CDT, 11:00 a.m. EDT. The conference call dial-in number for U.S. callers is 877-312-8776 and for international callers is 408-774-4007. The conference ID is 53290557. Please dial in to the conference at least five minutes before the call is scheduled to begin.

The call may also be accessed through the company's website, at www.nanophase.com, by clicking on the link under News Center and Calendar of Events to listen to a webcast of the event.

Use of Non-GAAP Financial Information

Nanophase believes that the presentation of results excluding certain items, such as non-cash equity compensation charges, provides meaningful supplemental information to both management and investors, facilitating the evaluation of performance across reporting periods. The Company uses these non-GAAP measures for internal planning and reporting purposes. These non-GAAP measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP measures used by other companies. The presentation of this additional information is not meant to be considered in isolation or as a substitute for net income or net income per share prepared in accordance with generally accepted accounting principles.

About Nanophase Technologies

Nanophase Technologies Corporation (NANX), www.nanophase.com, is a leader in nanomaterials technologies and provides nanoengineered solutions for multiple industrial product applications. Using a platform of patented and proprietary integrated nanomaterial technologies, the Company creates products with unique performance attributes from two ISO 9001:2008 and ISO 14001 facilities. Nanophase delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media. 

Forward-Looking Statements

This press release contains words such as "expects," "shall," "will," "believes," and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company's current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company's results of operations, performance and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, without limitation, the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company's dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company's nanocrystalline materials; the Company's manufacturing capacity and product mix flexibility in light of customer demand; the Company's limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company's dependence on patents and protection of proprietary information; the resolution of litigation in which the Company may become involved; the impact of any potential new government regulations that could be difficult to respond to or too costly to comply with while remaining financially viable; the ability of the Company to maintain an appropriate electronic trading venue; and other factors described in the Company's Form 10-K filed March 29, 2013. In addition, the Company's forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties or other contingencies.

NANOPHASE TECHNOLOGIES CORPORATION
     
BALANCE SHEETS
     
ASSETS March 31, 
2013
(Unaudited)
December 31,
2012
     
Current assets:    
Cash and cash equivalents  $ 3,608,182  $ 4,124,234
Investments  30,000  30,000
Trade accounts receivable, less allowance for doubtful accounts of $6,000 on March 31, 2013 and on December 31, 2012  1,233,517  1,031,405
Other receivables, net  2,002  27,167
Inventories, net  1,021,331  1,138,482
Prepaid expenses and other current assets  359,608  240,870
Total current assets  6,254,640  6,592,158
     
Equipment and leasehold improvements, net  2,852,563  3,027,671
Other assets, net  29,214  29,829
   $ 9,136,417  $ 9,649,658
     
LIABILITIES AND STOCKHOLDERS' EQUITY    
Current liabilities:    
Current portion of capital lease obligations  $ 29,148  $ 34,526
Accounts payable  721,358  680,452
Accrued expenses  376,341  484,460
Total current liabilities  1,126,847  1,199,438
     
Long-term portion of capital lease obligations  33,652  62,755
Long-term deferred rent  635,634  636,628
Asset retirement obligations  155,416  153,967
   824,702  853,350
Stockholders' equity:    
Preferred stock, $.01 par value, 24,088 shares authorized and no shares issued and outstanding  --   --
Common stock, $.01 par value, 35,000,000 shares authorized; 28,468,162 and 28,458,162 shares issued and outstanding on March 31, 2013 and December 31, 2012   284,682  284,582
Additional paid-in capital  95,584,143  95,512,065
Accumulated deficit  (88,683,957)  (88,199,777)
Total stockholders' equity  7,184,868  7,596,870
   $ 9,136,417  $ 9,649,658
NANOPHASE TECHNOLOGIES CORPORATION
     
STATEMENTS OF OPERATIONS
     
(Unaudited)
     
  Three months ended
March 31,
  2013 2012
     
Revenue:    
Product revenue  $ 2,975,721  $ 2,330,293
Other revenue  3,632  79,045
Total revenue  2,979,353  2,409,338
     
Operating expense:    
Cost of revenue  2,073,098  1,845,651
Gross profit  906,255  563,687
     
Research and development expense  428,730  399,614
Selling, general and administrative expense  960,668  944,315
Loss from operations   (483,143)  (780,242)
Interest income  317  -- 
Interest expense  (7,354)  (1,105)
Other, net  6,000  7,225
Loss before provision for income taxes  (484,180)  (774,122)
     
Provision for income taxes  --   -- 
Net loss  $ (484,180)  $ (774,122)
     
     
Net loss per share-basic and diluted  $ (0.02)  $ (0.04)
     
Weighted average number of basic and diluted common shares outstanding  28,466,717  21,208,162
     
     
NANOPHASE TECHNOLOGIES CORPORATION
     
STATEMENTS OF OPERATIONS - EXPANDED SCHEDULE
     
(Unaudited)
     
   Three months ended
March 31
  2013 2012
Revenue:    
Product revenue, net  $ 2,975,721  $ 2,330,293
Other revenue  3,632  79,045
Total revenue  2,979,353  2,409,338
     
Operating expense:    
Cost of revenue detail:    
Depreciation  179,732  200,680
Non-Cash equity compensation  7,597  8,489
Other costs of revenue  1,885,769  1,636,482
Cost of revenue  2,073,098  1,845,651
Gross profit  906,255  563,687
     
Research and development expense detail:    
Depreciation  33,078  32,595
Non-Cash equity compensation  21,174  21,757
Other research and development expense  374,478  345,262
Research and development expense  428,730  399,614
     
Selling, general and administrative expense detail:    
Depreciation and amortization  13,415  20,437
Non-Cash equity compensation  48,231  52,161
Other selling, general and administrative expense  899,022  871,717
Selling, general and administrative expense  960,668  944,315
Loss from operations   (483,143)  (780,242)
Interest income  317  -- 
Interest expense  (7,354)  (1,105)
Other, net  6,000  7,225
Loss before provision for income taxes  (484,180)  (774,122)
Provision for income taxes  --   -- 
Net loss  $ (484,180)  $ (774,122)
     
Non-GAAP Disclosure (see note regarding Non-GAAP disclosures):    
Addback Interest, net  7,037  1,105
Addback Depreciation/Amortization  226,225  253,712
Addback Non-Cash Equity Compensation  77,002  82,407
     
Adjusted EBITDA  $ (173,916)  $ (436,898)


            

Contact Data